Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on May 1st. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 5/1/2026.
- Sold $1,001 – $15,000 in shares of SS&C Technologies (NASDAQ:SSNC) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Wayfair (NYSE:W) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Sensata Technologies (NYSE:ST) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 4/29/2026.
Revvity Price Performance
Shares of RVTY traded down $0.19 during trading hours on Tuesday, hitting $98.76. 179,307 shares of the stock were exchanged, compared to its average volume of 1,304,380. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company has a market cap of $11.04 billion, a price-to-earnings ratio of 47.25, a price-to-earnings-growth ratio of 2.18 and a beta of 1.05. The stock’s 50-day moving average price is $90.38 and its two-hundred day moving average price is $96.96.
Revvity Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is currently 13.40%.
Wall Street Analysts Forecast Growth
RVTY has been the topic of a number of recent research reports. The Goldman Sachs Group lowered their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Wells Fargo & Company upped their price target on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. JPMorgan Chase & Co. reduced their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Barclays upped their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Four investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Revvity presently has an average rating of “Hold” and a consensus target price of $107.73.
Read Our Latest Report on Revvity
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. boosted its position in shares of Revvity by 6.0% during the 1st quarter. PNC Financial Services Group Inc. now owns 39,319 shares of the company’s stock worth $3,445,000 after purchasing an additional 2,240 shares during the period. Cassaday & Co Wealth Management LLC purchased a new position in shares of Revvity during the first quarter worth $84,000. Dimensional Fund Advisors LP boosted its position in shares of Revvity by 11.7% during the first quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company’s stock worth $255,623,000 after buying an additional 305,837 shares during the period. Roubaix Capital LLC grew its stake in shares of Revvity by 4.8% in the first quarter. Roubaix Capital LLC now owns 64,013 shares of the company’s stock valued at $5,608,000 after buying an additional 2,908 shares in the last quarter. Finally, Bessemer Group Inc. lifted its stake in Revvity by 0.7% during the 1st quarter. Bessemer Group Inc. now owns 40,622 shares of the company’s stock worth $3,559,000 after acquiring an additional 271 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Revvity Company Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Read More
- Five stocks we like better than Revvity
- The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000
- MP Materials Is Quietly Building a Rare Earth Powerhouse
- AI Demand Fuels Strong Q1 Earnings for Constellation Energy
- Sony’s $4 Billion Bet on Rock & Roll Royalties
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
